Skip to main content
. Author manuscript; available in PMC: 2019 Jan 2.
Published in final edited form as: Vaccine. 2017 Nov 22;36(1):6–14. doi: 10.1016/j.vaccine.2017.11.027

Table 2.

Live births, antenatal and delivery care, and use of hepatitis B vaccine birth dose (HepB-BD)—World Health Organization South-East Asia Region, 2011–2015.

Country Live births
(2015) [10]
Women who
received ≥ 1 antenatal
care visit (%) [9]
Institutional
deliveries (%) [9]
Births attended
by skilled birth
attendant (%) [9]
Introduction of
Hepatitis B vaccine
birth dose (year)
HepB-BD coverage per WUENIC (%) [7]

2011 2012 2013 2014 2015
Universal birth dose
Bhutan 12,860 98 74 75 2011 [7] 29 60 64 78 78
DPR Korea 344,435 100 95 100 2003 [7] 99 99 99 99 97
India 27,420,000 74 79 52 2012 [16,17] 8 23 37 41 44
Indonesia 4,893,435 95 70 87 2002 [14] 80a 80a 84a 86a 82a
Maldives 7233 99 95 96 2000 [7] 98 99 99 99 99
Thailand 675,530 98 100 100 1992 [13] 99 99 99 99 99
Timor-Leste 44,854 84 22 29 2016
Selective birth dose
Myanmar 1,023,892 83 36 71 2016
No birth dose
Bangladesh 3,228,362 64 37 42
Nepal 614,666 68 55 56
Sri Lanka 334,821 99 98 99
SEAR 38,600,088 50 59b 9 [8] 19 [8] 29 [8] 32 [8] 34 [8]

HepB-BD: hepatitis B vaccine birth dose; SEAR: South-East Asia Region; WUENIC: WHO-UNICEF National Immunization Coverage estimates.

a

Coverage data for Indonesia comes from official country estimates http://apps.who.int/immunization_monitoring/globalsummary/.

b

World Health Organization. Health Service data by region. Available at: http://apps.who.int/gho/data/view.main.1610?lang=en [accessed 23 March 2017].